United HealthCare US antitrust case against Jazz over Xyrem dismissed after settlement
MLex Summary: Jazz Pharmaceuticals secured dismissal of United HealthCare Services's antitrust case over an alleged scheme to delay entry of a generic version of narcolepsy drug Xyrem, following a settlement between...To view the full article, register now.
Already a subscriber? Click here to view full article